Search the web
Welcome, Guest
[Sign Out, My Account]
 EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI 		Symbol Lookup | Financial Search
EXEL > SEC Filings for EXEL > Form 8-K on 25-Jan-2013All Recent SEC Filings

Show all filings for EXELIXIS, INC. | Request a Trial to NEW EDGAR Online Pro

Form 8-K for EXELIXIS, INC.

25-Jan-2013

Other Events


Item 8.01 Other Events.

On January 24, 2013, Exelixis, Inc. announced the commercial availability of COMETRIQ™ (cabozantinib) for the treatment of patients with progressive, metastatic medullary thyroid cancer in the United States. The U.S. Food and Drug Administration approved COMETRIQ on November 29, 2012. COMETRIQ is being distributed exclusively through Diplomat Specialty Pharmacy in the United States.

  Add EXEL to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for EXEL - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now

Copyright © 2013 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.